Posted by Michael Wonder on 14 Dec 2021
Galderma receives FDA approval for new Sculptra label, offering more options to aesthetic partners
13 December 2021 - New label update allows for immediate use after reconstitution and more convenient administration of Sculptra with the optional addition of lidocaine for increased patient comfort.
Galderma announced today the new label for Sculptra (injectable poly-L-lactic acid (PLLA)), the first and only FDA approved PLLA facial injectable treatment that helps stimulate the skin’s own collagen production, to smooth facial wrinkles, such as smile lines.
